Abstract
Disparities in the progression of ten chronic overlapping pain conditions (COPC) and four comorbid mental disorders among traditionally underrepresented populations have rarely been reported in the literature. In this study, we conducted retrospective cohort analyses using All of Us Research Program data from 1981 to 2022 to address this issue. Separate cohorts were created to assess the disparities by sex, race, and ethnicity. Logistic regression models, controlling for demographic variables, were employed to identify significant disparity factors associated with the progression from one COPC or mental condition to another. Among 122 frequent disease pairs, we identified demographic disparities in nine progression pathways. For example, we found an increased likelihood of subsequent depression after irritable bowel syndrome in Hispanics versus non-Hispanic individuals (OR:3.13, p<10−10). To our knowledge, this is the first study to unveil demographic disparities in COPC progression. These findings underscore the importance of examining health disparities among individuals affected by multiple chronic pain conditions.
Author Summary Understanding the disparities in chronic overlapping pain conditions (COPC) can aid patients and clinicians in managing and optimizing therapy. Although disparities have been extensively reported for individual COPCs, progression disparity between conditions has been rarely studied. This study addresses this gap by identifying multiple disparities related to sex, race, and ethnicity in COPC progression, providing valuable insights for patients and clinicians to help prevent the exacerbation of other COPCs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
A IRB waiver was received for the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The original data can be accessed from All of Us Research Workbench, after registered as a control tier user.
